(Q24242031)

English

Metal protein attenuating compounds for the treatment of Alzheimer's disease

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Metal protein attenuating compounds for the treatment of Alzheimer's disease (English)

0 references

1 reference

Elizabeth L Sampson

1

0 references

Lydia Jenagaratnam

series ordinal

2

0 references

Rupert McShane

series ordinal

3

0 references

publication date

23 January 2008

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Current status of metals as therapeutic targets in Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Treatment of Alzheimer's disease with clioquinol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

The metallobiology of Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Clioquinol for the treatment of Alzheimer's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005380.PUB3

retrieved

21 January 2018

Identifiers

DOI

10.1002/14651858.CD005380.PUB3

0 references

PubMed publication ID

18254079

0 references

(Q24242031)

Metal protein attenuating compounds for the treatment of Alzheimer's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)